Cargando…

Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study

The progression of head and neck squamous cell carcinoma (HNSCC) is stimulated by various angiogenic peptides and growth factors. A correlation between tumor progression and the secretion of various serological mediators in patients with malignant tumors of the head and neck is of major interest for...

Descripción completa

Detalles Bibliográficos
Autores principales:	ADERHOLD, CHRISTOPH, GROBSCHMIDT, GUIDO MANUEL, SAUTER, ALEXANDER, FABER, ANNE, HÖRMANN, KARL, SCHULTZ, JOHANNES DAVID
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114600/ https://www.ncbi.nlm.nih.gov/pubmed/25120668 http://dx.doi.org/10.3892/ol.2014.2312

Ejemplares similares

Interaction of a CD44+ head and neck squamous cell carcinoma cell line with a stromal cell-derived factor-1-expressing supportive niche: An in vitro model
por: FABER, ANNE, et al.
Publicado: (2014)

Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1993)

Interleukin-15 deficient rats have reduced osteopontin at the maternal-fetal interface
por: Baines, Kelly J., et al.
Publicado: (2023)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
por: Maleš, Josip, et al.
Publicado: (2021)

Interleukin-6 serum level and monocyte production in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1992)

Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients
por: Cottin, Sylvine Carrondo, et al.
Publicado: (2018)

Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Choudhary, Moaz M., et al.
Publicado: (2016)

Changes of Plasma Interleukin-1 Receptor Antagonist, Interleukin-8 and other Serologic Markers during Chemotherapy in Patients with Active Pulmonary Tuberculosis
por: Lee, Jin Hwa, et al.
Publicado: (2003)

Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
por: Stanam, Aditya, et al.
Publicado: (2016)

Indicators for secondary carcinoma in head and neck cancer patients following curative therapy: A retrospective clinical study
por: Kuhlin, Beatrice, et al.
Publicado: (2020)

The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway
por: Xu, Qiaoshi, et al.
Publicado: (2020)

High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6
por: Chen, Guang-Liang, et al.
Publicado: (2016)

Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines
por: Wohlleben, Gisela, et al.
Publicado: (2015)

Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
por: Gore, M. E., et al.
Publicado: (1992)

Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
por: Uz, Uzdan, et al.
Publicado: (2021)

Interleukin-33 in Malignancies: Friends or Foes?
por: Shen, Jia-Xin, et al.
Publicado: (2018)

Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial
por: Rühle, Alexander, et al.
Publicado: (2021)

Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?
por: Ergen, Elizabeth N., et al.
Publicado: (2018)

Expression of Interleukin-1ß and Interleukin-8 in Oral Potentially Malignant Disorders and Carcinomas
por: Lopez-Labady, Jeaneth, et al.
Publicado: (2021)

Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis
por: Kovarik, Johannes J., et al.
Publicado: (2017)

Interferon-gamma and interleukin-10 production by mononuclear cells from patients with advanced head and neck cancer
por: Conti-Freitas, Luiz C, et al.
Publicado: (2012)

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2019)

Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma
por: Suzuki, Shinsuke, et al.
Publicado: (2022)

Serum Interleukin-6 as a Serologic Marker of Chronic Periapical Lesions: A Case-control Study
por: Abdolsamadi, Hamid Reza, et al.
Publicado: (2008)

Endoscopic/External Approaches in Otorhinolaryngology and Head and Neck Surgery
por: Betka, Jan, et al.
Publicado: (2015)

Macromolecular osteolytic factor synthesised by squamous carcinoma cell lines from the head and neck in vitro is interleukin 1.
por: Meghji, S., et al.
Publicado: (1988)

Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: a meta-analysis
por: Niu, Yu-Ming, et al.
Publicado: (2015)

The Role of Interleukin-33 in Head and Neck Squamous Cell Carcinoma Is Determined by Its Cellular Sources in the Tumor Microenvironment
por: Peng, Liang, et al.
Publicado: (2021)

Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Glass, Oliver, et al.
Publicado: (2018)

Interleukin-7 and Interleukin-15 for Cancer
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma
Publicado: (1989)

Immune Regulation of Interleukin-27 in Malignant Pleural Effusion
por: Li, Shi, et al.
Publicado: (2015)

Interleukin-1 Beta—A Friend or Foe in Malignancies?
por: Bent, Rebekka, et al.
Publicado: (2018)

Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies
por: Lodewijckx, Inge, et al.
Publicado: (2021)

The role of interleukin-15 in the development and treatment of hematological malignancies
por: Sindaco, Paola, et al.
Publicado: (2023)

Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma
por: GAO, JIAN, et al.
Publicado: (2016)

Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients
por: Lee, Meng-Hua, et al.
Publicado: (2018)

Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages
por: Huang, Wei, et al.
Publicado: (2017)

Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system
por: Vordermark, Dirk, et al.
Publicado: (2006)

Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer
por: Polat, Bülent, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_602mf9v1kkfdg3degrrkm5nnt4